Go Pro

QT Imaging (QTI) Competitors

QT Imaging logo
$2.53 -0.02 (-0.78%)
Closing price 04:00 PM Eastern
Extended Trading
$2.51 -0.02 (-0.87%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

QTI vs. INGN, APYX, CNXU, ECOR, and KEQU

Should you buy QT Imaging stock or one of its competitors? QT Imaging's main competitors and comparable companies include Inogen (INGN), Apyx Medical (APYX), Conexeu Sciences (CNXU), electroCore (ECOR), and Kewaunee Scientific (KEQU). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does QT Imaging compare to Inogen?

QT Imaging (NASDAQ:QTI) and Inogen (NASDAQ:INGN) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, analyst recommendations, risk, valuation, institutional ownership, media sentiment, profitability and dividends.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
QT Imaging
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Inogen
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.50

Inogen has a net margin of -6.94% compared to QT Imaging's net margin of -77.25%. Inogen's return on equity of -13.17% beat QT Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
QT Imaging-77.25% -1,202.69% -46.76%
Inogen -6.94%-13.17%-8.36%

QT Imaging has higher earnings, but lower revenue than Inogen. Inogen is trading at a lower price-to-earnings ratio than QT Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
QT Imaging$18.92M1.84-$21.08M-$1.57N/A
Inogen$348.67M0.46-$22.75M-$0.90N/A

In the previous week, Inogen had 3 more articles in the media than QT Imaging. MarketBeat recorded 5 mentions for Inogen and 2 mentions for QT Imaging. Inogen's average media sentiment score of 0.80 beat QT Imaging's score of 0.28 indicating that Inogen is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
QT Imaging
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
Inogen
1 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

QT Imaging has a beta of 0.02, meaning that its share price is 98% less volatile than the broader market. Comparatively, Inogen has a beta of 1.49, meaning that its share price is 49% more volatile than the broader market.

24.2% of QT Imaging shares are held by institutional investors. Comparatively, 89.9% of Inogen shares are held by institutional investors. 25.4% of QT Imaging shares are held by company insiders. Comparatively, 2.5% of Inogen shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Inogen beats QT Imaging on 11 of the 16 factors compared between the two stocks.

How does QT Imaging compare to Apyx Medical?

QT Imaging (NASDAQ:QTI) and Apyx Medical (NASDAQ:APYX) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, media sentiment, risk and dividends.

Apyx Medical has a consensus price target of $6.50, suggesting a potential upside of 160.00%. Given Apyx Medical's stronger consensus rating and higher possible upside, analysts clearly believe Apyx Medical is more favorable than QT Imaging.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
QT Imaging
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Apyx Medical
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.75

Apyx Medical has higher revenue and earnings than QT Imaging. Apyx Medical is trading at a lower price-to-earnings ratio than QT Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
QT Imaging$18.92M1.84-$21.08M-$1.57N/A
Apyx Medical$52.84M1.99-$11.21M-$0.20N/A

24.2% of QT Imaging shares are owned by institutional investors. Comparatively, 55.3% of Apyx Medical shares are owned by institutional investors. 25.4% of QT Imaging shares are owned by insiders. Comparatively, 15.9% of Apyx Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Apyx Medical has a net margin of -14.78% compared to QT Imaging's net margin of -77.25%. Apyx Medical's return on equity of -76.60% beat QT Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
QT Imaging-77.25% -1,202.69% -46.76%
Apyx Medical -14.78%-76.60%-13.91%

QT Imaging has a beta of 0.02, indicating that its share price is 98% less volatile than the broader market. Comparatively, Apyx Medical has a beta of 1.45, indicating that its share price is 45% more volatile than the broader market.

In the previous week, Apyx Medical had 11 more articles in the media than QT Imaging. MarketBeat recorded 13 mentions for Apyx Medical and 2 mentions for QT Imaging. Apyx Medical's average media sentiment score of 0.42 beat QT Imaging's score of 0.28 indicating that Apyx Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
QT Imaging
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
Apyx Medical
2 Very Positive mention(s)
1 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

Summary

Apyx Medical beats QT Imaging on 15 of the 17 factors compared between the two stocks.

How does QT Imaging compare to Conexeu Sciences?

QT Imaging (NASDAQ:QTI) and Conexeu Sciences (NASDAQ:CNXU) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, media sentiment, valuation, profitability and risk.

Conexeu Sciences has lower revenue, but higher earnings than QT Imaging. Conexeu Sciences is trading at a lower price-to-earnings ratio than QT Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
QT Imaging$18.92M1.84-$21.08M-$1.57N/A
Conexeu SciencesN/AN/A-$3.92M-$0.40N/A

Conexeu Sciences has a net margin of 0.00% compared to QT Imaging's net margin of -77.25%. Conexeu Sciences' return on equity of -200.20% beat QT Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
QT Imaging-77.25% -1,202.69% -46.76%
Conexeu Sciences N/A -200.20%-177.26%

Conexeu Sciences has a consensus price target of $20.00, indicating a potential upside of 502.41%. Given Conexeu Sciences' higher probable upside, analysts plainly believe Conexeu Sciences is more favorable than QT Imaging.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
QT Imaging
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Conexeu Sciences
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

24.2% of QT Imaging shares are held by institutional investors. 25.4% of QT Imaging shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, QT Imaging had 1 more articles in the media than Conexeu Sciences. MarketBeat recorded 2 mentions for QT Imaging and 1 mentions for Conexeu Sciences. Conexeu Sciences' average media sentiment score of 0.91 beat QT Imaging's score of 0.28 indicating that Conexeu Sciences is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
QT Imaging
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
Conexeu Sciences
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

QT Imaging and Conexeu Sciences tied by winning 6 of the 12 factors compared between the two stocks.

How does QT Imaging compare to electroCore?

QT Imaging (NASDAQ:QTI) and electroCore (NASDAQ:ECOR) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, dividends, profitability, risk and valuation.

QT Imaging has a beta of 0.02, meaning that its share price is 98% less volatile than the broader market. Comparatively, electroCore has a beta of 1.05, meaning that its share price is 5% more volatile than the broader market.

electroCore has a net margin of -39.96% compared to QT Imaging's net margin of -77.25%. electroCore's return on equity of 0.00% beat QT Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
QT Imaging-77.25% -1,202.69% -46.76%
electroCore -39.96%N/A -81.35%

electroCore has a consensus price target of $18.00, indicating a potential upside of 74.59%. Given electroCore's higher possible upside, analysts clearly believe electroCore is more favorable than QT Imaging.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
QT Imaging
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
electroCore
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, QT Imaging and QT Imaging both had 2 articles in the media. electroCore's average media sentiment score of 0.92 beat QT Imaging's score of 0.28 indicating that electroCore is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
QT Imaging
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
electroCore
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

electroCore has higher revenue and earnings than QT Imaging. electroCore is trading at a lower price-to-earnings ratio than QT Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
QT Imaging$18.92M1.84-$21.08M-$1.57N/A
electroCore$32.03M2.90-$13.97M-$1.66N/A

24.2% of QT Imaging shares are held by institutional investors. Comparatively, 26.7% of electroCore shares are held by institutional investors. 25.4% of QT Imaging shares are held by insiders. Comparatively, 7.8% of electroCore shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

electroCore beats QT Imaging on 9 of the 13 factors compared between the two stocks.

How does QT Imaging compare to Kewaunee Scientific?

Kewaunee Scientific (NASDAQ:KEQU) and QT Imaging (NASDAQ:QTI) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, dividends, media sentiment, risk, analyst recommendations, valuation and institutional ownership.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
QT Imaging
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Kewaunee Scientific has higher revenue and earnings than QT Imaging. QT Imaging is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kewaunee Scientific$282M0.35$9.62M$2.7612.29
QT Imaging$18.92M1.84-$21.08M-$1.57N/A

Kewaunee Scientific has a net margin of 2.97% compared to QT Imaging's net margin of -77.25%. Kewaunee Scientific's return on equity of 11.61% beat QT Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
Kewaunee Scientific2.97% 11.61% 4.82%
QT Imaging -77.25%-1,202.69%-46.76%

Kewaunee Scientific has a beta of 0.76, indicating that its share price is 24% less volatile than the broader market. Comparatively, QT Imaging has a beta of 0.02, indicating that its share price is 98% less volatile than the broader market.

32.7% of Kewaunee Scientific shares are held by institutional investors. Comparatively, 24.2% of QT Imaging shares are held by institutional investors. 14.1% of Kewaunee Scientific shares are held by company insiders. Comparatively, 25.4% of QT Imaging shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, QT Imaging had 1 more articles in the media than Kewaunee Scientific. MarketBeat recorded 2 mentions for QT Imaging and 1 mentions for Kewaunee Scientific. Kewaunee Scientific's average media sentiment score of 0.60 beat QT Imaging's score of 0.28 indicating that Kewaunee Scientific is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Kewaunee Scientific
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
QT Imaging
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

Summary

Kewaunee Scientific beats QT Imaging on 10 of the 14 factors compared between the two stocks.

Get QT Imaging News Delivered to You Automatically

Sign up to receive the latest news and ratings for QTI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

QTI vs. The Competition

MetricQT ImagingHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$35.04M$5.50B$7.22B$13.08B
Dividend YieldN/A1.80%2.53%15.88%
P/E Ratio-1.6124.42272.6425.80
Price / Sales1.8468.18607.7390.99
Price / CashN/A32.6877.3851.29
Price / Book4.695.6110.516.26
Net Income-$21.08M$150.14M$3.50B$360.95M
7 Day PerformanceN/A-2.18%-2.48%-1.89%
1 Month Performance-8.66%-4.87%-5.65%-3.43%
1 Year Performance6.98%3.84%9.54%2.60%

QT Imaging Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
QTI
QT Imaging
1.1204 of 5 stars
$2.53
-0.8%
N/A+2.0%$35.04M$18.92MN/A32
INGN
Inogen
1.2508 of 5 stars
$5.23
+2.8%
N/A-35.5%$135.08M$354.30MN/A753
APYX
Apyx Medical
2.8217 of 5 stars
$2.83
-4.1%
$6.60
+133.2%
+14.5%$124.27M$52.84MN/A205
CNXU
Conexeu Sciences
3.0645 of 5 stars
$3.96
-5.9%
$20.00
+405.1%
N/A$124.11MN/AN/A4
ECOR
electroCore
3.0464 of 5 stars
$11.35
-0.6%
$18.00
+58.6%
+120.6%$110.81M$32.03MN/A83

Related Companies and Tools


This page (NASDAQ:QTI) was last updated on 10/1/2026 by MarketBeat.com Staff.
From Our Partners